CIM
JAZZ icon

Confluence Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Confluence Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,475
Closed -$315K – 315
2021
Q4 		$315K Sell
2,475
-703
-22% -$92.4K ﹤0.01% 261
2021
Q3 		$414K Buy
3,178
+84
+3% +$12.7K 0.01% 245
2021
Q2 		$550K Buy
3,094
+667
+27% +$116K 0.01% 231
2021
Q1 		$399K Sell
2,427
-121
-5% -$19.9K 0.01% 245
2020
Q4 		$421K Sell
2,548
-1,039
-29% -$155K 0.01% 245
2020
Q3 		$511K Sell
3,587
-183
-5% -$22.7K 0.01% 227
2020
Q2 		$416K Sell
3,770
-64
-2% -$7.08K 0.01% 237
2020
Q1 		$382K Sell
3,834
-409
-10% -$52.9K 0.01% 240
2019
Q4 		$605K Buy
4,243
+218
+5% +$29.7K 0.01% 225
2019
Q3 		$516K Sell
4,025
-218
-5% -$29.2K 0.01% 233
2019
Q2 		$605K Buy
4,243
+118
+3% +$15.9K 0.01% 225
2019
Q1 		$590K Sell
4,125
-535
-11% -$69.8K 0.01% 222
2018
Q4 		$578K Sell
4,660
-493
-10% -$73.1K 0.01% 232
2018
Q3 		$866K Sell
5,153
-300
-6% -$51.6K 0.01% 223
2018
Q2 		$940K Buy
+5,453
New +$891K 0.02% 221

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Confluence Investment Management's JAZZ Position: Q1 2022 in Review

Confluence Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2022, closing a stake of 2,475 shares — an estimated $315K sold.

Confluence Investment Management first reported a position in JAZZ in Q2 2018 and held it in 15 quarters. The position peaked at $940K in Q2 2018. 462 funds tracked by Wall St. Rank hold JAZZ as of Q1 2022.

  • Confluence Investment Management reported no remaining Jazz Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Confluence Investment Management sold 2,475 Jazz Pharmaceuticals shares in Q1 2022, an estimated $315K.
  • Confluence Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2018 and held it in 15 quarters.
  • Confluence Investment Management's Jazz Pharmaceuticals position peaked at $940K in Q2 2018.
  • 462 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2022.

Based on Confluence Investment Management's 13F filing for Q1 2022, filed 4 Apr 2022.